News – Page 387 – Endpoints News

UK initiates review of clinical trials after decreases in recruitment, number of studies

3 years ago

CMS to work closely with FDA on accelerated approval payment reforms

3 years ago

PharmaEssentia takes Besremi rare blood cancer message to consumers

3 years ago

Cerevel blames Covid for delayed neuroscience studies, says president is leaving

3 years ago

Pfizer, Bayer lay off staff in California; Moderna signs gene editing deal with David Hallal biotech

3 years ago

Apellis jumps on the cash train after FDA approves its GA drug

3 years ago

Rubius fails to find alternative as board approves dissolution

3 years ago

Another BioCryst Factor D inhibitor hits clinical delay two months after first one discontinued

3 years ago

Vivek Ramaswamy launches bid for US presidency, resigns from Roivant board

3 years ago

Kinnate engineers $24M deal to win control of China joint venture back from OrbiMed, Foresite

3 years ago

Tangled in bankruptcy proceedings and legal tussle, Sorrento secures $75M to stay afloat

3 years ago

BioNTech touts differences with Moderna in race for cancer vaccines

3 years ago

FDA to take another look at Akebia's rejected kidney drug

3 years ago

Big Pharma has harsh words for UK's ballooning voluntary reimbursement agreement

3 years ago

BIO renews video series with new pharma partners, including Pfizer, Eli Lilly and Merck

3 years ago

Myeloid Therapeutics goes down under for new manufacturing site, with $66M local investment

3 years ago

MarketingRx roundup: CVS amps Moderna’s CMV vaccine trial; Another star in Pfizer’s Covid vaccination sky

3 years ago

The new pharma celebrities: Famous patients with social influence are ‘just getting started’

3 years ago

Merck falls short in PhIII Covid-19 prophylaxis trial, joining Pfizer

3 years ago

Cancer biotech ends trial, searches for sale or other route

3 years ago

Bridge Biotherapeutics' ulcerative colitis drug fails Phase II trial; biotech plans to push forward

3 years ago

Alnylam gets an adcomm for Onpattro treatment in ATTR amyloidosis

3 years ago

Updated: Leena Gandhi leaves Dana-Farber for checkpoint inhibitor biotech

3 years ago

A small Connecticut biotech throws hat into IPO ring

3 years ago

First page Previous page 384 385 386387388 389 390 Next page Last page